Axxcess Wealth Management LLC lowered its holdings in Aflac Incorporated (NYSE:AFL – Free Report) by 51.4% during the fourth quarter, Holdings Channel.com reports. The firm owned 2,988 shares of the financial services provider’s stock after selling 3,155 shares during the period. Axxcess Wealth Management LLC’s holdings in Aflac were worth $309,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently bought and sold shares of the business. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Aflac by 6.4% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,694,511 shares of the financial services provider’s stock valued at $524,846,000 after acquiring an additional 281,148 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in shares of Aflac by 1.5% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 3,226,681 shares of the financial services provider’s stock valued at $333,768,000 after acquiring an additional 47,119 shares during the period. Amundi lifted its stake in shares of Aflac by 81.1% during the fourth quarter. Amundi now owns 2,753,513 shares of the financial services provider’s stock valued at $285,181,000 after acquiring an additional 1,232,683 shares during the period. Guinness Asset Management LTD lifted its stake in shares of Aflac by 5.2% during the fourth quarter. Guinness Asset Management LTD now owns 2,395,045 shares of the financial services provider’s stock valued at $247,682,000 after acquiring an additional 118,720 shares during the period. Finally, Assetmark Inc. lifted its stake in shares of Aflac by 2.0% during the fourth quarter. Assetmark Inc. now owns 1,616,772 shares of the financial services provider’s stock valued at $167,239,000 after acquiring an additional 32,220 shares during the period. Institutional investors and hedge funds own 67.44% of the company’s stock.
Insider Buying and Selling
In related news, EVP Audrey B. Tillman sold 24,744 shares of the stock in a transaction that occurred on Friday, December 27th. The stock was sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the completion of the transaction, the executive vice president now directly owns 222,618 shares of the company’s stock, valued at approximately $23,018,701.20. This represents a 10.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $107.63, for a total value of $107,630.00. Following the transaction, the director now directly owns 25,393 shares of the company’s stock, valued at $2,733,048.59. This trade represents a 3.79 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 55,546 shares of company stock worth $5,863,616. 0.80% of the stock is owned by corporate insiders.
Aflac Stock Down 0.6 %
Aflac (NYSE:AFL – Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. On average, sell-side analysts expect that Aflac Incorporated will post 6.88 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on AFL shares. StockNews.com raised Aflac from a “sell” rating to a “hold” rating in a research note on Friday, February 14th. BMO Capital Markets initiated coverage on Aflac in a report on Thursday, January 23rd. They issued a “market perform” rating and a $111.00 price objective for the company. Keefe, Bruyette & Woods dropped their price objective on Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a report on Wednesday, February 12th. Evercore ISI dropped their price objective on Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a report on Wednesday, December 4th. Finally, JPMorgan Chase & Co. upped their price objective on Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a report on Tuesday, January 7th. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, Aflac currently has a consensus rating of “Hold” and an average price target of $103.36.
Get Our Latest Stock Analysis on AFL
Aflac Company Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
See Also
- Five stocks we like better than Aflac
- P/E Ratio Calculation: How to Assess Stocks
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- How to Choose Top Rated Stocks
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- The 3 Best Fintech Stocks to Buy Now
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.